Zurich Coronavirus Cohort

Switzerland
|
2020
  • Adults (18-64 years)
  • General population
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Post COVID-19 condition

EuCARE-HOSPITALISED

Sweden Italy Poland Portugal Germany Lithuania United Kingdom Kenya Brazil Mexico
|
2022
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Blood sample
  • Nasopharyngeal swab
  • Urine sample

EuCARE-POSTCOVID

Italy Poland Portugal Lithuania Brazil Mexico Germany
|
2022
  • Adults (18-64 years)
  • Hospital
  • Primary care
  • Non-hospital health centre
  • Emergency department
  • Long-term care facility
  • SARS-CoV-2
  • Post COVID-19 condition
  • Blood sample
  • Nasopharyngeal swab

MERMAIDS 2

Serbia Estonia Greece Montenegro Italy Romania Spain The Netherlands
|
2022-2022
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood

ORCHESTRA WP2 prospective cohort

France Italy Spain Congo Argentina The Netherlands
|
2020-2024
  • Adults (18-64 years)
  • Hospital
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition
  • Acute COVID-19
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood
  • Plasma

VERDIQual

United Kingdom Thailand Italy Nigeria
|
2023-2025
  • Adults (18-64 years)
  • Monkeypox virus
  • Mpox

ADEQUATE

Serbia Belgium
|
2021-2025
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Syndromic diagnostic testing

REACT

Spain Denmark South Africa
|
2022-2026
  • Adults (18-64 years)
  • Hospital
  • Primary care
  • SARS-CoV-2
  • Influenza virus
  • Acute COVID-19
  • Influenza
  • Blood sample
  • PBMC
  • Serum
  • Whole blood
  • Plasma

Siciliano

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Primary care
  • Monkeypox virus
  • Mpox

SILENT 2

Belgium
|
2021-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Sobral-Costas

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Cidofovir

Solan

Spain
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Rehabilitation